Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy
Clinical trial NCT00083616 · COMPLETED
Trial details
- NCT number
- NCT00083616
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2007-05-01
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.